Development and evaluation of mobile health applications during chemotherapy intermission in breast cancer based on hospital-community-home continuing care model: a randomized controlled study

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100047251

Enrollment

Unknown

Registered

2021-06-11

Start date

2021-07-01

Completion date

Unknown

Last updated

2022-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Experimental group:Routine continuing care and Mobile Health Apps

Control group:Routine continuing care

Eligibility

Sex/Gender

Female

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years; 2. The pathological diagnosis was I or II or IIIa; 3. About to complete the first course of chemotherapy after mastectomy; 4. Having the abilities to read and write Chinese; 5. The patients or her family members living with have smart phones.

Exclusion criteria

Exclusion criteria: 1. Unaware of the disease; 2. Patient with mental disorders; 3. Patient with limb dysfunction; 4. Patient with suicidal tendencies; 5. Patient who is illiterate or semi-literate.

Design outcomes

Primary

Measure	Time frame
The quality of life;	—

Secondary

Measure	Time frame
Upper limb shoulder joint function;Uncertainty of disease;Psychological elastic;Utilization of community health services;	—

Countries

China

Contacts

Public ContactWang Liping

Hangzhou Normal University

wangliping111@126.com+86 15356641080

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026